Go Pro
→ Grab Your First Trade Playbook (link expires) (From Profits Run) (Ad)tc pixel Free MCTA Stock Alerts

Charming Medical (MCTA) Competitors

Charming Medical logo
$29.36 -0.01 (-0.02%)
As of 07/21/2026
Compare

MCTA vs. VRDN, AGL, SNDA, WGS, and TDOC

Should you buy Charming Medical stock or one of its competitors? MarketBeat compares Charming Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charming Medical include Viridian Therapeutics (VRDN), Agilon Health (AGL), Sonida Senior Living (SNDA), GeneDx (WGS), and Teladoc Health (TDOC). These companies are all part of the "healthcare" industry.

How does Charming Medical compare to Viridian Therapeutics?

Viridian Therapeutics (NASDAQ:VRDN) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

Viridian Therapeutics currently has a consensus price target of $38.79, suggesting a potential upside of 102.33%. Given Viridian Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Viridian Therapeutics is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viridian Therapeutics
1 Sell rating(s)
0 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.86
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Charming Medical has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -490.31%. Charming Medical's return on equity of 0.00% beat Viridian Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Viridian Therapeutics-490.31% -80.19% -48.84%
Charming Medical N/A N/A N/A

Charming Medical has lower revenue, but higher earnings than Viridian Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viridian Therapeutics$70.85M27.89-$342.60M-$3.32N/A
Charming MedicalN/AN/AN/AN/AN/A

In the previous week, Viridian Therapeutics had 3 more articles in the media than Charming Medical. MarketBeat recorded 3 mentions for Viridian Therapeutics and 0 mentions for Charming Medical. Viridian Therapeutics' average media sentiment score of 0.58 beat Charming Medical's score of 0.00 indicating that Viridian Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Viridian Therapeutics Positive
Charming Medical Neutral

Summary

Viridian Therapeutics beats Charming Medical on 6 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Agilon Health?

Agilon Health (NYSE:AGL) and Charming Medical (NASDAQ:MCTA) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Agilon Health currently has a consensus price target of $64.00, suggesting a potential downside of 46.85%. Given Agilon Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Agilon Health is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Agilon Health had 4 more articles in the media than Charming Medical. MarketBeat recorded 4 mentions for Agilon Health and 0 mentions for Charming Medical. Agilon Health's average media sentiment score of 0.23 beat Charming Medical's score of 0.00 indicating that Agilon Health is being referred to more favorably in the media.

Company Overall Sentiment
Agilon Health Neutral
Charming Medical Neutral

Charming Medical has lower revenue, but higher earnings than Agilon Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.34-$391.35M-$21.56N/A
Charming MedicalN/AN/AN/AN/AN/A

Charming Medical has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Charming Medical's return on equity of 0.00% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-6.09% -146.03% -24.55%
Charming Medical N/A N/A N/A

Summary

Agilon Health beats Charming Medical on 6 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Charming Medical (NASDAQ:MCTA) are both small-cap services companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Charming Medical has a net margin of 0.00% compared to Sonida Senior Living's net margin of -24.15%. Charming Medical's return on equity of 0.00% beat Sonida Senior Living's return on equity.

Company Net Margins Return on Equity Return on Assets
Sonida Senior Living-24.15% -36.98% -7.08%
Charming Medical N/A N/A N/A

Sonida Senior Living presently has a consensus target price of $41.25, suggesting a potential upside of 2.95%. Given Sonida Senior Living's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sonida Senior Living is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonida Senior Living
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Charming Medical has lower revenue, but higher earnings than Sonida Senior Living.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sonida Senior Living$381.14M4.98-$70.78M-$5.83N/A
Charming MedicalN/AN/AN/AN/AN/A

87.6% of Sonida Senior Living shares are owned by institutional investors. 39.3% of Sonida Senior Living shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Sonida Senior Living had 1 more articles in the media than Charming Medical. MarketBeat recorded 1 mentions for Sonida Senior Living and 0 mentions for Charming Medical. Sonida Senior Living's average media sentiment score of 0.69 beat Charming Medical's score of 0.00 indicating that Sonida Senior Living is being referred to more favorably in the media.

Company Overall Sentiment
Sonida Senior Living Positive
Charming Medical Neutral

Summary

Sonida Senior Living beats Charming Medical on 8 of the 11 factors compared between the two stocks.

How does Charming Medical compare to GeneDx?

Charming Medical (NASDAQ:MCTA) and GeneDx (NASDAQ:WGS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Charming Medical has higher earnings, but lower revenue than GeneDx.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charming MedicalN/AN/AN/AN/AN/A
GeneDx$427.54M4.35-$21.02M-$2.68N/A

Charming Medical has a net margin of 0.00% compared to GeneDx's net margin of -17.58%. GeneDx's return on equity of 9.15% beat Charming Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Charming MedicalN/A N/A N/A
GeneDx -17.58%9.15%5.21%

GeneDx has a consensus price target of $87.43, suggesting a potential upside of 39.66%. Given GeneDx's stronger consensus rating and higher possible upside, analysts clearly believe GeneDx is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
GeneDx
2 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.56

In the previous week, GeneDx had 33 more articles in the media than Charming Medical. MarketBeat recorded 33 mentions for GeneDx and 0 mentions for Charming Medical. GeneDx's average media sentiment score of 0.21 beat Charming Medical's score of 0.00 indicating that GeneDx is being referred to more favorably in the news media.

Company Overall Sentiment
Charming Medical Neutral
GeneDx Neutral

61.7% of GeneDx shares are held by institutional investors. 25.2% of GeneDx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

GeneDx beats Charming Medical on 10 of the 11 factors compared between the two stocks.

How does Charming Medical compare to Teladoc Health?

Charming Medical (NASDAQ:MCTA) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

In the previous week, Teladoc Health had 5 more articles in the media than Charming Medical. MarketBeat recorded 5 mentions for Teladoc Health and 0 mentions for Charming Medical. Teladoc Health's average media sentiment score of 0.41 beat Charming Medical's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media.

Company Overall Sentiment
Charming Medical Neutral
Teladoc Health Neutral

Teladoc Health has a consensus price target of $7.73, suggesting a potential downside of 13.25%. Given Teladoc Health's stronger consensus rating and higher probable upside, analysts plainly believe Teladoc Health is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24

76.8% of Teladoc Health shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Charming Medical has higher earnings, but lower revenue than Teladoc Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charming MedicalN/AN/AN/AN/AN/A
Teladoc Health$2.53B0.64-$200.32M-$0.97N/A

Charming Medical has a net margin of 0.00% compared to Teladoc Health's net margin of -6.81%. Charming Medical's return on equity of 0.00% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Charming MedicalN/A N/A N/A
Teladoc Health -6.81%-11.45%-5.54%

Summary

Teladoc Health beats Charming Medical on 8 of the 11 factors compared between the two stocks.

Get Charming Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCTA vs. The Competition

Export
MetricCharming MedicalServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$497.21M$2.02B$18.38B$12.68B
Dividend YieldN/AN/A5.12%9.42%
P/E RatioN/A26.3818.7023.95
Price / SalesN/A6.8037.1193.75
Price / CashN/A2,138.07361.9260.45
Price / BookN/A29.5712.016.16
Net IncomeN/A-$30.36M-$15.57M$331.73M
7 Day PerformanceN/A10.57%-1.81%-1.96%
1 Month PerformanceN/A15.27%-3.45%-2.49%
1 Year PerformanceN/AN/A-22.35%17.21%

Charming Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCTA
Charming Medical
N/A$29.36
0.0%		N/AN/A$497.21MN/AN/A49
VRDN
Viridian Therapeutics
3.4213 of 5 stars		$19.08
+0.5%		$38.79
+103.3%		+14.2%$1.96B$70.85MN/A50
AGL
Agilon Health
1.2745 of 5 stars		$121.67
+5.0%		$64.00
-47.4%		+134.8%$1.93B$5.93BN/A1,076
SNDA
Sonida Senior Living
1.8141 of 5 stars		$40.02
-0.6%		$41.25
+3.1%		N/A$1.91B$381.14MN/A5,140
WGS
GeneDx
4.1766 of 5 stars		$62.43
-2.2%		$87.43
+40.0%		-21.3%$1.90B$427.54MN/A1,300

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MCTA) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners
America’s answer to universal basic income
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
TSM just handed Trump's secretive AI project $100 billion
Taiwan Semiconductor just committed another $100 billion to U.S. chip manufacturing - on top of $165 billion a...
InvestorPlace | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Elon is about to dominate the biggest arms race in tech history
Microsoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...
The Oxford Club | Sponsoredtc pixel
Wall Street legend put 60% in one stock — here’s the ticker
One of America's most famous investors put 60% of his fund into a single stock - and Whitney Tilson of Stansbe...
Stansberry Research | Sponsoredtc pixel
It all happens tonight.
Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...
Trade Thirsty | Sponsoredtc pixel